1 / 18

Comparative Effectiveness Research: A Benefit for Consumers?

This article discusses the potential benefits of comparative effectiveness research in healthcare, focusing on key issues such as organizational structure, stakeholder engagement, cost-effectiveness, and funding. It also highlights the importance of unbiased and evidence-based information in making informed healthcare decisions.

dutton
Download Presentation

Comparative Effectiveness Research: A Benefit for Consumers?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. How Can Comparative Effectiveness Research Benefit Consumers? Second National Congress on the Un and Under Insured September 23, 2008 Gail Shearer Consumers Union

  2. “Comparative Effectiveness” Everyone is talking about it!

  3. “Comparative Effectiveness” Confusion about what it is!

  4. “Comparative Effectiveness” Stakes are high: If history is a guide…

  5. Key Issues • Organizational structure • How to engage stakeholders AND avoid conflict of interest? • Include cost-effectiveness? • How succeed when so many early efforts failed? • How fund?

  6. Identifying CR Best Buy Drugs • Start with credible source of unbiased, rigorous analysis of clinical evidence about drug effectiveness (DERP) • Intense medical input through consultants, internal CU review, and medical peer review • Selections based on effectiveness, safety record, and price

  7. Possible Annual Savings: 5 Categories • Statins $1,300 (cholesterol) • Proton Pump Inhibitors: $1,740 (acid reflux and ulcers) • NSAIDs $2,200 (arthritis and pain) • Anti-depressants $1,200 • Beta Blockers $1,900 (high blood pressure)

  8. Average Cost Plan Highest Cost Plan

  9. Quality Improvement Organization funded by CMS to provide technical assistance to providers • CR Best Buy Drugs materials used to educate both staff & consumers in 4 physician practices • Goal: Increase use of generic statins among diabetic patients • Delaware law encourages pharmacists to substitute generics: Prescription for brand w/generic alternative a vital step

  10. Baseline Follow Up Change in Prescribing Patterns

  11. Changing from this model of provision of information:

  12. To unbiased, evidence-based information:

More Related